Skip to content
Wholesale trade
KZActiveBIN 010940010050
Plans from 2 000 ₸ a month
1/17
High risk
Not present at its registered address
To risks

ТОО "ФИЛ-ФАРМ"

Director
Худякова Ольга Нурмухамедовна
Incorporated
21.09.2001
Address
Шымкент ул. ГАГАРИНА
РНН
582100022551

This is a company preview

Unlock the full report for 1 check — contacts, bank accounts, court cases, government contracts, arrests, licenses and PDF export.

The pack is not a subscription, its checks last 30 days

Risks

1/17
Not present at its registered addressHigh risk

Комитет государственных доходов · data as of 14.01.2026

This assessment is informational and analytical only, based on our internal methodology and open sources; it is not an official government conclusion or a guarantee of reliability.

Procurement signals

Court cases

Arrests & encumbrances

Enforcement proceedings

Certificates

Licenses

Profile

Summary

Full name
ТОВАРИЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "ФИЛ-ФАРМ"
BIN
010940010050
Status
Active
Director
Худякова Ольга Нурмухамедовна
Registration date
21.09.2001
Activity
Оптовая торговля фармацевтическими товарами, кроме торговли медицинской техникой и ортопедическими изделиями
Legal address
Шымкент ул. ГАГАРИНА

In government contracts over 2 years

VAT payer
Yes, since 06.05.2025
КАТО
791910000
РНН
582100022551
КФС
Собственность иностранных физических лиц
КСЕ
Нефинансовые корпорации под иностранным контролем – ОПП
Company size
Малые предприятия
Employees
от 0 до 5 чел.
Procurement role
Поставщик

Activities

1
46461primary

Оптовая торговля фармацевтическими товарами, кроме торговли медицинской техникой и ортопедическими изделиями

Download

Contacts

Change history

Financials

Tax payments

6

By year · ₸

2026
3.2M
2025
1.2M-56%
2024
2.8M+61%
2023
1.7M+325%
2022
407.2K+1274%
2021
29.6K
·3.2M
2026year to date
-56%1.2M
2025
+61%2.8M
2024
+325%1.7M
2023
+1274%407.2K
2022
·29.6K
2021
2026
Tax paid3,154,556 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
2025
Tax paid1,238,643 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
2024
Tax paid2,784,291 ₸
Penalty200,150 ₸
Fine0 ₸
VAT refund0 ₸
2023
Tax paid1,732,018 ₸
Penalty10 ₸
Fine0 ₸
VAT refund0 ₸
2022
Tax paid407,167 ₸
Penalty120 ₸
Fine0 ₸
VAT refund0 ₸
2021
Tax paid29,643 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
Estimated taxable profit

Estimate: corporate income tax ÷ 0%. Not a filing and not revenue — the taxable profit implied by the corporate income tax paid. Actual profit differs by deductions, carried-forward losses and reduced rates.

Download

Financial statements

Premium

Public contracts

What it sells and where

Samruk-Kazyna procurement

Tender bids

Procurement as a customer

Assets

Bank accounts

Management & owners

Leadership

2
  • ХО

    Худякова Ольга Нурмухамедовна

    Director

Former directors

  • ЫНЫДЫРЫСОВ НҰРБОЛ ЕРКІНҰЛЫ
Download

Founders

Accreditations

Employees

Affiliated companies

Premium

Director's involvement in other legal entities

Branches

Relations & mentions

Company networks

Premium

Similar companies

Media mentions

Company summary

ТОО "ФИЛ-ФАРМ" (BIN 010940010050) is an active legal entity in Шымкент, registered in 2001 (25 years on the market). Primary activity — оптовая торговля фармацевтическими товарами, кроме торговли медицинской техникой и ортопедическими изделиями. Per open government registries as of November 7, 2026: 176 government contracts on Портал государственных закупок РК (goszakup.gov.kz) worth 122,886,877 ₸. Automated screening found 1 risk indicator for "ФИЛ-ФАРМ". Director on record — Худякова Ольга Нурмухамедовна. Data current as of November 7, 2026.

Information is aggregated from open government registries of Kazakhstan: Министерство юстиции РК, Комитет государственных доходов МФ РК, Верховный Суд РК, Портал государственных закупок РК, АО «Самрук-Казына», Бюро национальной статистики РК, Портал электронного лицензирования. Data is indexed automatically and may lag behind primary sources; the absence of a record does not guarantee the absence of the corresponding facts. This is reference information and does not replace an official extract. Learn more about the methodology and sources — SafeDeal editorial policy.